LG
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Cardiomeds, an mHealth App for Self-Management to Support Swiss Patients With Heart Failure : 2-Stage Mixed Methods Usability Study | JMIR formative research |  | 2025 | 7 | 16 | ||
| Swiss-Meds: An App Fostering Medication Adherence of Swiss Patient | Studies in health technology and informatics | | 2019 | 209 | 370 | ||
| SMART-MEDS: Development of a Medication Adherence App for Acute Coronary Syndrome Patients based on a Gamified Behaviour Change Model | AMIA Annual Symposium proceedings | | 2018 | 420 | 152 | ||
| P-glycoprotein: a clue to vitamin K antagonist stabilization | Pharmacogenomics |  | 2015 | 702 | 0 | ||
| Identification and weighting of the most critical "real-life" drug-drug interactions with acenocoumarol in a tertiary care hospital | European journal of clinical pharmacology | | 2013 | 876 | 759 | ||
| Role of P-glycoprotein in the uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell model | Basic & clinical pharmacology & toxicology | | 2013 | 600 | 3 | ||
| Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatment | Pharmacogenomics | | 2013 | 687 | 0 | ||
| Anticoagulation par antivitamines K: analyse des interactions médicamenteuses et des polymorphismes génétiques à l'origine de la variabilité de la réponse et des risques liés à l'acénocoumarol | | 2012 | 905 | 1,460 | |||
| Introduction de l'acénocoumarol à l'aide d'un algorithme de prescription | Revue médicale suisse | 2010 | 621 | 0 |
